Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
BMJ Case Reports|June 18, 2013
Antineutrophil cytoplasm antibody-positive pulmonary-renal syndrome in a patient with diffuse cutaneous systemic sclerosisLennart Tonneijck, Anisha Tanna, Charles D Pusey
The Lancet. Diabetes & Endocrinology|October 8, 2018
Lixisenatide and renal outcomes in patients with type 2 diabetes and acute coronary syndrome: an exploratory analysis of the ELIXA randomised, placebo-controlled trialMarcel H A Muskiet, Lennart Tonneijck, Yao Huang, et al.
Gut|January 21, 2016
GLP-1 based therapies: clinical implications for gastroenterologistsMark M Smits, Daniel H van Raalte, Lennart Tonneijck, et al.
Nephrology (Carlton, Vic.)|August 21, 2019
Plasma uric acid and renal haemodynamics in type 2 diabetes patientsDanii Ls Suijk, Mark M Smits, Marcel Ha Muskiet, et al.
Diabetes Research and Clinical Practice|January 14, 2017
The effects of GLP-1 based therapies on postprandial haemodynamics: Two randomised, placebo-controlled trials in overweight type 2 diabetes patientsMark M Smits, Lennart Tonneijck, Marcel H A Muskiet, et al.
European Journal of Endocrinology|October 26, 2016
Heart rate acceleration with GLP-1 receptor agonists in type 2 diabetes patients: an acute and 12-week randomised, double-blind, placebo-controlled trialMark M Smits, Lennart Tonneijck, Marcel H A Muskiet, et al.
British Journal of Clinical Pharmacology|November 27, 2015
Exenatide acutely increases heart rate in parallel with augmented sympathetic nervous system activation in healthy overweight malesMark M Smits, Marcel H A Muskiet, Lennart Tonneijck, et al.
The Lancet. Diabetes & Endocrinology|May 7, 2015
Pleiotropic effects of type 2 diabetes management strategies on renal risk factorsMarcel H A Muskiet, Lennart Tonneijck, Mark M Smits, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 4, 2017
SGLT2 Inhibition in the Diabetic Kidney-From Mechanisms to Clinical OutcomeErik J M van Bommel, Marcel H A Muskiet, Lennart Tonneijck, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 25, 2015
GLP-1 Receptor Agonist Exenatide Increases Capillary Perfusion Independent of Nitric Oxide in Healthy Overweight MenMark M Smits, Marcel H A Muskiet, Lennart Tonneijck, et al.
Pageof 4